ERIC RYAN WILLIAMS

Allopathic & Osteopathic Physicians|Ophthalmology BLUE ASH, OH NPI 1205367182

General Payments — all program years on this page

$2,269.26

  • Category: General Payments
  • Program years: PY2018–2024
  • Record count: 59
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $417.76 across 20 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $417.7620

By paying entity

Latest program year (PY2024) · sorted by reported total.

By program year

Program yearAmountRecords
2018 $99.991
2019 $43.082
2021 $106.352
2022 $901.2816
2023 $700.8018
2024 $417.7620

Records — PY2024 (20)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1092826702 Alimera Sciences, Inc. $16.99 08/14/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1092834217 Alimera Sciences, Inc. $14.40 06/13/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1092838425 Alimera Sciences, Inc. $22.19 10/09/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1092840781 Alimera Sciences, Inc. $24.38 06/24/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1106340909 ABBVIE INC. $21.17 04/05/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1106340911 ABBVIE INC. $17.29 08/08/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1114255323 Regeneron Healthcare Solutions, Inc. $32.72 02/14/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1114255327 Regeneron Healthcare Solutions, Inc. $26.14 06/19/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1114255331 Regeneron Healthcare Solutions, Inc. $28.53 07/11/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1114255335 Regeneron Healthcare Solutions, Inc. $21.27 08/30/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1114255338 Regeneron Healthcare Solutions, Inc. $29.51 11/05/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1133008752 Genentech USA, Inc. $15.68 05/02/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1133008756 Genentech USA, Inc. $17.72 07/24/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1133008760 Genentech USA, Inc. $15.52 08/28/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1133008764 Genentech USA, Inc. $13.09 10/31/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1133008768 Genentech USA, Inc. $23.65 11/21/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1140342528 Bausch & Lomb Americas Inc. $22.50 07/25/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1154020865 Apellis Pharmaceuticals, Inc. $18.29 09/18/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1154020867 Apellis Pharmaceuticals, Inc. $18.36 04/25/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1154020869 Apellis Pharmaceuticals, Inc. $18.36 02/22/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.